Prudential Financial
ITCI

Prudential Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Prudential Financial’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,030
Closed -$545K – 2534
2025
Q1 		$545K Buy
6,030
+1,740
+41% +$217K ﹤0.01% 1802
2024
Q4 		$358K Sell
4,290
-22,193
-84% -$1.82M ﹤0.01% 1942
2024
Q3 		$1.94M Sell
26,483
-94,518
-78% -$7.1M ﹤0.01% 1516
2024
Q2 		$8.29M Sell
121,001
-44,827
-27% -$3.11M 0.01% 724
2024
Q1 		$11.5M Buy
165,828
+83,817
+102% +$5.76M 0.02% 633
2023
Q4 		$5.87M Buy
82,011
+54,917
+203% +$3.16M 0.01% 858
2023
Q3 		$1.44M Sell
27,094
-77,940
-74% -$4.54M ﹤0.01% 1563
2023
Q2 		$6.65M Buy
105,034
+14,103
+16% +$879K 0.01% 784
2023
Q1 		$5.02M Buy
90,931
+22,041
+32% +$1.07M 0.01% 871
2022
Q4 		$3.65M Buy
68,890
+37,108
+117% +$1.86M 0.01% 1012
2022
Q3 		$1.48M Sell
31,782
-253,783
-89% -$13.3M ﹤0.01% 1525
2022
Q2 		$16.3M Buy
285,565
+1,967
+0.7% +$112K 0.03% 513
2022
Q1 		$17.4M Buy
283,598
+167,433
+144% +$8.7M 0.02% 543
2021
Q4 		$6.08M Buy
116,165
+38,872
+50% +$1.63M 0.01% 923
2021
Q3 		$2.88M Buy
77,293
+22,646
+41% +$787K ﹤0.01% 1281
2021
Q2 		$2.23M Buy
+54,647
New +$2.02M ﹤0.01% 1423

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Prudential Financial's ITCI Position: Q2 2025 in Review

Prudential Financial sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 6,030 shares — an estimated $545K sold.

Prudential Financial first reported a position in ITCI in Q2 2021 and held it in 16 quarters. The position peaked at $17.4M in Q1 2022. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Prudential Financial reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Prudential Financial sold 6,030 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $545K.
  • Prudential Financial first reported a position in Intra-Cellular Therapies Inc. in Q2 2021 and held it in 16 quarters.
  • Prudential Financial's Intra-Cellular Therapies Inc. position peaked at $17.4M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Prudential Financial's 13F filing for Q2 2025, filed 12 Aug 2025.